Since 2001, the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease has been a valuable resource for healthcare professionals. Freshly updated for 2017, the latest edition of the Global Strategy document is the premiere evidence-based reference tool for the implementation of effective disease management plans, and represents the current best practices for the care of people living with COPD.
New in this major update is a revised and improved ABCD assessment tool, which now places more emphasis on a patient’s symptom burden when evaluating disease severity. In addition, new recommendations concerning ongoing self-management and education programs, a more stepwise approach to the use of inhaled corticosteroids, and enhanced outpatient transition criteria are presented. The Global Strategy also now recommends the use of interprofessional care management throughout all levels of care, and provides new evidence for pulmonary rehabilitation and palliative care.
Virtually every component of the Global Strategy document has been updated, featuring the latest research data and expert opinion. GOLD is fortunate to have an international network of distinguished health professionals from a variety of disciplines, who continue to evaluate new clinical evidence as it becomes available, and GOLD will continue to provide updates to the Global Strategy when this new evidence suggests changes to practice. GOLD will also continue to work with our National Leaders team and other interested health professionals to increase COPD awareness among legislators, public health officials, and the general public, so that all can work together toward the development of new programs for the detection, prevention, and management of COPD.